6J98
 
 | |
7YSI
 | | Crystal structure of thioredoxin 2 | | Descriptor: | Thiol disulfide reductase thioredoxin, ZINC ION | | Authors: | Chang, Y.J, Park, H.H. | | Deposit date: | 2022-08-12 | | Release date: | 2023-03-15 | | Last modified: | 2023-11-29 | | Method: | X-RAY DIFFRACTION (1.202 Å) | | Cite: | Comparison of the structure and activity of thioredoxin 2 and thioredoxin 1 from Acinetobacter baumannii.
Iucrj, 10, 2023
|
|
7XAO
 | | Crystal structure of thioredoxin 1 | | Descriptor: | Thioredoxin | | Authors: | Chang, Y.J, Park, H.H. | | Deposit date: | 2022-03-18 | | Release date: | 2022-06-01 | | Last modified: | 2023-11-29 | | Method: | X-RAY DIFFRACTION (1.45 Å) | | Cite: | High-resolution crystal structure of Acinetobacter baumannii thioredoxin 1.
Biochem.Biophys.Res.Commun., 608, 2022
|
|
4UIP
 | | The complex structure of extracellular domain of EGFR with Repebody (rAC1). | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, EPIDERMAL GROWTH FACTOR RECEPTOR, ... | | Authors: | Kang, Y.J, Cha, Y.J, Cho, H.S, Lee, J.J, Kim, H.S. | | Deposit date: | 2015-03-31 | | Release date: | 2015-11-25 | | Last modified: | 2024-01-10 | | Method: | X-RAY DIFFRACTION (2.95 Å) | | Cite: | Enzymatic Prenylation and Oxime Ligation for the Synthesis of Stable and Homogeneous Protein-Drug Conjugates for Targeted Therapy.
Angew.Chem.Int.Ed.Engl., 54, 2015
|
|
1WKQ
 | |
